Gastrulation is a morphogenetic process in which tightly coordinated cell and tissue movements establish the three germ layers (ectoderm, mesoderm, and endoderm) to define the anterior-to-posterior embryonic organization [1] . To elicit this movement, cells modulate membrane protrusions and undergo dynamic cell interactions. Here we report that ankyrin repeats domain protein 5 (xANR5), a novel FGF target gene product, regulates cell-protrusion formation and tissue separation, a process that develops the boundary between the ectoderm and mesoderm [2, 3] , during Xenopus gastrulation. Loss of xANR5 function by antisense morpholino oligonucleotide (MO) caused a short trunk and spina bifida without affecting mesodermal gene expressions. xANR5-MO also blocked elongation of activin-treated animal caps (ACs) and tissue separation. The dorsal cells of xANR5-MO-injected embryos exhibited markedly reduced membrane protrusions, which could be restored by coinjecting active Rho. Active Rho also rescued the xANR5-MO-inhibited tissue separation. We further demonstrated that xANR5 interacted physically and functionally with paraxial protocadherin (PAPC), which has known functions in cell-sorting behavior, tissue separation, and gastrulation cell movements [4] [5] [6] , to regulate early morphogenesis. Our findings reveal for the first time that xANR5 acts through Rho to regulate gastrulation and is an important cytoplasmic partner of PAPC, whose cytoplasmic partner was previously unknown.
Gastrulation is a morphogenetic process in which tightly coordinated cell and tissue movements establish the three germ layers (ectoderm, mesoderm, and endoderm) to define the anterior-to-posterior embryonic organization [1] . To elicit this movement, cells modulate membrane protrusions and undergo dynamic cell interactions. Here we report that ankyrin repeats domain protein 5 (xANR5), a novel FGF target gene product, regulates cell-protrusion formation and tissue separation, a process that develops the boundary between the ectoderm and mesoderm [2, 3] , during Xenopus gastrulation. Loss of xANR5 function by antisense morpholino oligonucleotide (MO) caused a short trunk and spina bifida without affecting mesodermal gene expressions. xANR5-MO also blocked elongation of activin-treated animal caps (ACs) and tissue separation. The dorsal cells of xANR5-MO-injected embryos exhibited markedly reduced membrane protrusions, which could be restored by coinjecting active Rho. Active Rho also rescued the xANR5-MO-inhibited tissue separation. We further demonstrated that xANR5 interacted physically and functionally with paraxial protocadherin (PAPC), which has known functions in cell-sorting behavior, tissue separation, and gastrulation cell movements [4] [5] [6] , to regulate early morphogenesis. Our findings reveal for the first time that xANR5 acts through Rho to regulate gastrulation and is an important cytoplasmic partner of PAPC, whose cytoplasmic partner was previously unknown.
Results and Discussion
XL023o21, which Encodes Ankyrin Repeats Domain Protein 5, Is a Novel FGF Target We previously performed a screening with dorsal marginal zone (DMZ) explants treated with the FGF receptor inhibitor SU5402. From this screen, XL023o21 was isolated as a downregulated gene [7] . In the DMZ, the endogenous expression of XL023o21 was suppressed by a dominant-negative FGFR (XFD) or by SU5402 to the background level. Overexpression of eFGF caused the upregulation of XL023o21, which was suppressed by SU5402 treatment. The ectopic expression of eFGF in ACs upregulated XL023o21 expression in a concentration-dependent manner, and this increase was downregulated by SU5402 ( Figures 1A and 1B) . These data indicate that XL023o21 is an FGF-responsive gene.
XL023o21 encodes ankyrin repeats domain protein 5 (xANR5), which has two predicted functional domains ( Figure 1C ): both ends contain ankyrin repeats, which act as a scaffold for protein interactions and cytoskeleton binding [8] , and the intermediate region contains two EF-hand domains that bind calcium and modulate calcium signaling [9] . BLAST and XDB (http://Xenopus. nibb.ac.jp) searches showed that ANR5 is well conserved across vertebrates, suggesting that it has an evolutionarily important role during development. The Xenopus ANR5 and human ANR5 amino acid sequences show 53% identity and 70% similarity overall ( Figure 1C ). In addition, xANR5 shows 86% identity to its ortholog in Xenopus tropicalis (data not shown). xANR5 is maternally expressed during early embryogenesis, and its transcripts are almost ubiquitous but dorsally enriched in the gastrula (Figures S1A and S1B in the Supplemental Data available online). Intriguingly, the expression patterns of PAPC, Fz7, and Rho [5, 10] overlapped with that of xANR5 in the dorsal mesoderm, suggesting that these molecules might function in similar processes.
xANR5-MO Perturbs Early Embryonic Development
To elucidate the function of xANR5 during gastrulation, we performed gain-and loss-of-function analyses. Microinjection of xANR5 mRNA or xANR5-MO that specifically suppressed the expression of UTR-xANR5-Vns ( Figure 1D ) caused incomplete blastopore closure (data not shown) and a short trunk and spina bifida (S. B.) at the tadpole stage ( Figure 1E ). Remarkably, the morphological defects caused by xANR5-MO were rescued by the coinjection of xANR5, a rescue construct lacking the MO recognition site, or of hANR5 mRNA coinjection ( Figure 1E ). These results indicate that the phenotype was specifically due to xANR5 depletion and that ANR5's function is conserved across phylogeny. Despite the morphological defects, however, embryonic induction and patterning were not disturbed in the xANR5 mRNA-or xANR5-MO-injected embryos ( Figures S2A-S2E) .
We further demonstrated that xANR5-MO inhibited the elongation of activin-treated ACs without affecting mesodermal induction ( Figure S2E ), and this MOinduced inhibition was also efficiently rescued by the overexpression of hANR5 ( Figure 1F ). These data indicate again that the effect of xANR5-MO was not due to impaired mesodermal formation but rather due to a defect in cell movement. Further evidence for the function of xANR5 in regulating early morphogenetic movements was obtained by analyzing early gastrula that were fixed and sectioned sagittally along the dorsal midline. In the Xenopus gastrula, involuted mesodermal cells migrate *Correspondence: nueno@nibb.ac.jp away from the blastopore toward the animal pole by crawling on the blastocoel roof (BCR), which consists of noninvoluting ectodermal cells. The development of a morphologically identifiable boundary or cleft (Brachet's cleft) between the mesodermal and ectodermal layer prevents their cells from intermingling [2, 3] . Notably, in the embryos that received an xANR5-MO injection, the boundary between the BCR and the (C) Comparison of the protein structures of human ANR5 (hANR5) and Xenopus ANR5 (xANR5). The numbers above and inside the box indicate the amino acid residues and the percent identity between the two proteins, respectively. (D) The effect of xANR5-MO on the transcription of xANR5 mRNA was demonstrated with an in vitro transcription/translation system. xANR5-MO specifically inhibited the transcription of the UTR-including xANR5 mRNA (UTR-xANR5-Vns) constructed to generate a fusion protein with eYFP (Vns). The effect of xANR5-MO was restored by coexpression of a rescue construct (rescue-xANR5-Vns). xANR5 protein was detected by western blotting with an anti-GFP antibody. Vns protein was detected as a loading control. (E) Depletion of xANR5 by MO (16.8 ng per embryo) or the overexpression of xANR5 resulted in a short trunk (short) and S.B. These gastrulationdefective phenotypes caused by xANR5-MO were partially restored by the coinjection of xANR5, a rescue construct (500 pg), or hANR5 (400 pg). (F) When coinjected with activin, xANR5-MO abrogated the activin-induced elongation of animal caps, which was fully rescued by the coinjection of hANR5. 20 embryos that had received a microinjection of mRNA or MOs were used for AC isolation at the blastula stage. Ten explants each were used to examine activin-induced elongation and for RT-PCR analysis. The data represent three different experiments. (G) Schematic diagram of a sagittally fractured early gastrula shows the tissue separation at the DMZ, indicated by the visually identifiable Brachet's cleft. Black arrows indicate the anterior and posterior ends of the cleft, respectively. Embryos fixed at stage 10.5 were fractured through the dorsal blastopore, and the Brachet's cleft formation was analyzed. The Con-MO-injected embryo showed a cleft that extended from the anterior to posterior end, whereas the xANR5-MO-injected embryo showed perturbed posterior cleft formation. Coinjection of a rescue construct restored the extension of the posterior cleft that was inhibited by xANR5-MO microinjection.
involuted mesoderm disappeared posteriorly, and Brachet's cleft was present only anteriorly. This result implies that tissue separation is abrogated by the knocking down of xANR5 expression. The inhibition of the cleft extension caused by xANR5-MO was specific, because the coinjection of a rescue construct (xANR5) led to a well-developed posterior cleft ( Figure 1G ).
Depletion of xANR5 Disrupts Cell Spreading and Cell Protrusion
Gastrulation is a fundamental morphogenetic process regulated by highly orchestrated movements of cells and tissues. For this movement to occur, cells must achieve dynamic modulation of protrusions that are important for the cell motility [1, 11, 12] . We found that DMZ in which xANR5 function had been lost did not show convergent extension (CE) at stage 14, whereas the control-MO (Con-MO)-injected DMZ showed good CE (Figure S3A) . Furthermore, at an earlier stage (stage 13), the xANR5-MO-injected dorsal cells failed to become tightly coordinated and were round in shape. These cells produced reduced cell protrusions, such as filopodia and lamellipodia ( Figures S3B and S3C ). Our data indicate that xANR5 might modulate the cell protrusions. To investigate this possibility more directly, we next examined the morphology at a single-cell level, focusing on the cell protrusions.
Dorsal cells were dissociated from embryos that had received MO or mRNA injection and were incubated for 1 hr on a fibronectin-coated dish, to allow binding. The morphology of the cells that were attached to the fibronectin was then observed. Approximately 60% of the Con-MO-injected cells underwent spreading and flattening. However, the spreading of the xANR5-MOinjected cells was dramatically reduced, with only 10% of the cells showing spreading on fibronectin. The coinjection of a rescue construct restored the cell-spreading effect to the xANR5-MO-injected cells ( Figure 2A) .
The above results led us to examine the membrane morphology more closely, to determine whether the xANR5-MO modifies the dynamic membrane protrusions like filopodia and lamellipodia, which allow cellshape change and movements, and the loss of whose function can influence gastrulation [11, 12] . A membrane-bound form of Vns (mbVns) and the actin-binding domain of a moesin-bound form of RFP (moesin-abdRFP) were coinjected with MO and mRNA. To trace the dynamic movements of the protrusions, we took timelapse movies of individual cells. Con-MO-injected cells produced dynamic protrusions; the filopodia and lamellipodia were well extended and retracted. In contrast, the xANR5-MO-injected cells showed remarkably fewer and smaller protrusions, which were static and appeared frozen on the fibronectin, and actively generated shapeand location-transforming membrane blebs. The coexpression of the rescue construct with xANR5-MO rescued the effect caused by the loss of xANR5 function and resulted in the production of dynamic membrane protrusions ( Figure 2B and Figure S3D ).
It is also well known that protrusive cell morphology is regulated by the small GTPase Rho family [12] [13] [14] . Thus, we speculated that xANR5 requires the function of small GTPases for its regulation of cell protrusions. Intriguingly, the coexpression of a constitutively active form of Rho (CARho) prevented the reduced protrusions and increased membrane blebs that were induced by the loss of xANR5 function ( Figure 2B and Figure S3D ). We also found that Rho activity in the DMZ was significantly suppressed by xANR5-MO injection. Overexpression of xANR5 in the VMZ increased the Rho activation ( Figure 2C ). Taken together, these results clearly indicate that xANR5 regulates cell morphology by modulating Rho activity. In addition, these data are consistent with previous reports showing that the Rho family regulates cell-shape change, adhesion, and migration, which are mediated by the actin cytoskeleton [12] [13] [14] [15] . The coinjection of a constitutively active form of Rac (CARac) did not show a significant rescue effect on the protrusive morphology (data not shown).
xANR5-MO Influences Cell-Cell Adhesion
In our experiments, we noticed that the cells from xANR5-MO-injected embryos were rounded-up and loosely packed in dorsal explants ( Figure S3B ), suggesting that xANR5 might also control cell-cell adhesion. To test this possibility more directly, we assessed whether xANR5-MO could modulate cell-cell adhesion by using a dissociation and reaggregation assay. DMZs from embryos that had received a microinjection of MO or mRNA were isolated and dissociated in calcium-magnesiumfree medium (CMFM) with gentle shaking. We confirmed that the explants were well dissociated in CMFM. Calcium was added, and 2-3 hr later, the cells from the Con-MO-injected embryos had reaggregated and formed a large cell mass, whereas those from the xANR5-MO-injected embryos failed to reaggregate and remained dispersed ( Figure 2D) . Again, the coexpression of xANR5 rescued the effect of xANR5-MO and resulted in the production of cell clumps. These results support the idea that xANR5 regulates cell-cell adhesion.
xANR5 and PAPC Interact Synergistically in the Formation of Brachet's Cleft Rho is known as a cytoskeleton regulator. We found that Rho can also rescue the impaired cell morphology caused by xANR5-MO. Recently, Rho was reported to be involved in the development of Brachet's cleft [5] .
To examine the role of xANR5 and Rho in tissue separation, xANR5-MO ( Figure 1G ) and CARho were coinjected into the dorsovegetal side of embryos. Intriguingly, the CARho-coinjected embryos showed extension of the posterior cleft, although the effect was partial (Figure 3A) . This result supports the idea that xANR5 and Rho, whose activity is regulated by xANR5, interact in tissue separation. The coinjection of CARac with xANR5-MO failed to reverse the effect of xANR5-MO; rather, it exacerbated the xANR5-MO effect on the formation of Brachet's cleft. To examine further whether xANR5 influences the separation behavior, we carried out an in vitro tissue-separation assay as described previously [3, 5] . The coinjection of xANR5-MO abolished the separation behavior induced by BVg1 overexpression ( Figures S4A-S4C ), indicating that xANR5 has a role in the tissue separation.
It was previously demonstrated that XFz7 and PAPC enhance tissue separation, and conversely, that the knockdown of these proteins abolishes the development of Brachet's cleft nonredundantly [3, 5] . We therefore reasoned that xANR5 might interact with XFz7 or PAPC in regulating cleft formation. A low dose of xANR5-MO that was insufficient to inhibit cleft formation was coinjected with a low dose of XFz7-MO or PAPCMOs, followed by a careful analysis of the cleft formation. Surprisingly, when the levels of xANR5 and PAPC were simultaneously lowered by the coinjection of a low amount of each MO, cleft formation was synergistically inhibited; the extension of the posterior cleft was absent in approximately 50% of the embryos, and only about 20% of the embryos showed a wild-type cleft (Figure 3B) . However, the coinjection of low doses of xANR5-MO and XFz7-MO showed only an additive effect on the cleft formation, suggesting that xANR5 and XFz7 do not functionally interact. This result was somewhat unexpected, because a previous report showed that the coinjection of low amounts of PAPC-MO and XFz7-MO synergistically inhibited cleft formation, suggesting that these proteins had nonredundant functions. One explanation for the discrepancy is that cytoplasmic complexes or partners of these molecules might modulate or fine-tune each pathway. The tissue separation induced by XFz7 and PAPC requires, respectively, PKC-a activity and Rho activity. However, XFz7-dependent PKC-a activity does not participate in the PAPCdependent tissue separation [3, 5] . Our findings demonstrating that xANR5-MO and PAPC-MOs, but not xANR5-MO and XFz7-MO, have a synergistic effect on the development of Brachet's cleft imply that xANR5 interacts functionally with PAPC in the regulation of tissue separation. Consequently, we suggest that xANR5 might modulate PAPC function in the regulation of gastrulation.
xANR5 Is Colocalized and Physically Interacted with PAPC To determine whether xANR5 and PAPC form a complex as binding partners, we first examined the embryonic localization of these two molecules. We performed whole-mount in situ hybridization (WISH) and analyzed the expression patterns of xANR5 and PAPC at the gastrula stage. Embryos fixed at the gastrula stage were fractured sagittally and subjected to the WISH with a Fluorescein-labeled antisense xANR5 probe (xANR5-Fluorescein) and DIG-labeled antisense PAPC probe (PAPC-DIG) or vice versa. The embryos showed overlapping expression patterns of xANR5 and PAPC in the DMZ ( Figure 4A ). Next, we examined the subcellular localization of xANR5 and PAPC in ACs and the DMZ with a 6-repeat myc epitope-tagged xANR5 (MT-xANR5) and flag epitope-tagged PAPC (PAPC-flag). The localization of the two epitope-tagged proteins was detected by immunostaining. In ACs, xANR5 (green) was localized to the cytoplasm, apparently near the plasma membrane. In the spindle-shaped dorsal cells, xANR5 accumulated at the mediolateral ends, where the lamellipodial activity orchestrates directional cell movements [11] (Figure 4B ). These results were consistent with the localization of xANR5-Vns ( Figure S1C ). The expression of PAPC (red) was detected near the membrane and at the two tips of bipolarized cells in the AC and DMZ, respectively, as reported previously [6] . In a merged image, the colocalization of xANR5 and PAPC (yellow) was clearly detected near the cell membrane. Notably, in the spindle-shaped dorsal cells, both xANR5 and PAPC were concentrated at the two tips, where they showed overlapping expression ( Figure 4B) .
To examine the interaction of these two proteins more directly, we performed coimmunoprecipitation and pulldown assays with epitope-tagged proteins. We demonstrated that MT-xANR5 and PAPC-flag interacted in the immunoprecipitation assay ( Figure 4C ), and we confirmed the physical interaction of xANR5 and PAPC in a GST pull-down assay ( Figure S5A ). The physical interaction was specific, because we failed to detect any interaction between MT-xANR5 or xANR5-GST and the flag epitope alone. To identify which domain of xANR5 is required for this association, we made several deletion constructs of xANR5 fused with the GST epitope. Among the domains of xANR5, we identified the C-terminal ankyrin repeats domain as the mediator of the physical interaction of xANR5 and PAPC ( Figure S5A ).
Our findings suggest that PAPC and xANR5 have cooperative roles in gastrulation and further imply that the C-terminal ankyrin repeats domain might be critical in bridging the function of these two proteins. Roles of the cadherin superfamily during embryonic development have been extensively demonstrated [4] [5] [6] [16] [17] [18] [19] ; classical cadherins, which form cytoplasmic complexes with catenins, mediate diverse cell and tissue movements. The protocadherin family is also known to regulate tissue morphogeneses such as tissue separation, gastrulation cell movements, and neural fold formation during embryogenesis. However, unlike classical cadherins, little is known about the cytoplasmic partners or complexes of protocadherin. This is the first report that xANR5, a novel FGF target protein, forms a cytoplasmic complex through its C-terminal ankyrin repeats domain with PAPC, a member of the protocadherin family.
xANR5 Is Indispensable for the PAPC-Regulated Signaling Pathways
The results obtained above led us to speculate further that xANR5 might regulate PAPC-mediated signaling pathways. PAPC was recently proposed to have a signaling function in regulating JNK and Rho [5, 6] , which are important molecular components of the PCP pathway [20, 21] . First, we examined whether xANR5 is involved in the regulation of PAPC-dependent JNK activity. The MO and/or mRNA were coinjected with a GAL4-DBD-bound form of c-jun into two animal blastomeres at the 2-cell stage. JNK activity was detected by c-Jun phosphorylation. The overexpression of PAPC produced c-Jun phosphorylation, consistent with previous reports [5, 6] . The overexpression of xANR5 also increased the JNK activity. Furthermore, the c-Jun phosphorylation was much more enhanced by the coinjection of xANR5 and PAPC than by a single injection of xANR5 or PAPC. When PAPC and xANR5-MO were simultaneously introduced into the animal blastomeres, interestingly, xANR5-MO inhibited the c-Jun phosphorylation caused by PAPC overexpression, which in turn implies that xANR5-MO abrogated the PAPC-mediated JNK activation. The effect of xANR5-MO on this c-Jun phosphorylation was specific, because the coinjection of xANR5 could increase the JNK activity in the presence of xANR5-MO ( Figure 4D) .
Next, we carried out a Rho activation assay and examined whether xANR5-MO, which can also downregulate Rho activity in the DMZ, inhibits PAPC-dependent Rho activation. Microinjection of PAPC into the two ventral blastomeres at the 4-cell stage triggered the activation of Rho in the VMZ, where the activity is normally lower than in the DMZ [21, 22] . However, the ectopic Rho activity was reduced when xANR5-MO was coinjected with PAPC ( Figure 4E ). We further examined whether xANR5 could rescue the downregulated Rho activity by PAPC-MO injection in the DMZ. The innate Rho activity in the DMZ was reduced when PAPC-MO was injected into the two dorsal blastomeres at the 4-cell stage. The downregulated Rho activity was completely restored by the coinjection of xANR5, suggesting that xANR5 modulates the PAPC-regulated Rho activation ( Figure S5B ).
The importance of JNK and the Rho family proteins in cell and tissue movements is well conserved across phylogeny [12] [13] [14] [20] [21] [22] [23] . These proteins are critical elements of the cellular machinery associated with polarized cell motility and cytoskeletal behavior. Recent reports showed that PAPC modulates Rho activation, whose activity regulates not only cell movements but also tissue separation, and our findings were reminiscent of these observations. When xANR5-MO was injected into the dorsal region, we found defects in protrusive cell morphology and gastrulation cell movements. In these DMZs, the Rho activity was remarkably reduced and the formation of Brachet's cleft was inhibited. In addition, the inhibition of the cleft was exacerbated by the coinjection of xANR5-MO and PAPC-MOs. Taken together, the finding that xANR5-MO inhibited PAPC-dependent JNK and Rho activation supports the idea that xANR5 is required for cytoskeletal remodeling and cellular locomotion in PAPC-elicited intracellular responses.
Finally, we performed an embryonic rescue experiment to determine whether xANR5 could compensate for the effect caused by the PAPC-MOs. The microinjection of PAPC-MOs into the two dorsal blastomeres at the 4-cell stage produced phenotypes such as a short trunk and S.B. Interestingly, the coexpression of xANR5 mRNA restored the phenotypes caused by the PAPC knockdown, although this was a partial effect ( Figure 4F ). This rescue effect was also confirmed for the Rho activity ( Figure S5B ). These results clearly indicate that xANR5 plays an important role in the PAPC-dependent signaling pathways that regulate morphogenetic processes.
Conclusions
Our study shows that xANR5, which was identified from a microarray analysis with SU5402-treated DMZs, regulates cell-protrusive morphology and tissue separation in Xenopus gastrulation. Our findings support the idea that xANR5 functions in regulating early morphogenetic movements. The expression of xANR5 is enriched in DMZ and in the two tips of spindle-shaped dorsal cells, where extensive cell and tissue movements occur. xANR5 is colocalized with PAPC, which is known to regulate gastrulation cell movements and tissue separation. xANR5-MO caused defects in the cell-protrusive morphology that is critical for the dynamic cell-shape changes and cell motility by inhibiting Rho activity. In our previous report [12] , we demonstrated that NRH, another FGF target gene product, also regulates JNK activity, Rho activity, and protrusive cell morphology. In line with further elucidating the roles of FGF signaling during gastrulation, it would be intriguing to determine whether xANR5 and NRH interact functionally in these events. The knockdown of xANR5 abolished tissue separation and active Rho could rescue the effect of xANR5-MO, suggesting that Rho, an important regulator of the cytoskeleton and cell migration, is required for robust xANR5 activity during gastrulation. We further demonstrated that xANR5 not only physically interacts with PAPC through its C-terminal ankyrin repeats domain, but also functionally interacts in the regulation of JNK and Rho activity. The present work, which identifies a novel functional partner of PAPC in gastrulation regulation, provides further insight into the in vivo role and signaling mechanisms of the protocadherin family, whose cytoplasmic complexes are mostly unknown.
Experimental Procedures Embryos
Xenopus embryos were obtained by in vitro fertilization and staged according to Nieuwkoop and Faber [24] . For each experiment, the data from at least three different batches of embryos were collected. Embryonic manipulation was carried out as described [12] .
Antisense Morpholino Oligonucleotides
The antisense morpholino oligonucleotides (MOs) were obtained from Gene Tools (Philomath, OR). The MO sequences were as follows: xANR5-MO 5 0 -CTAGTCTTTCTTCTACCTCTGCCAT-3 0 ; PAPC-MOs 5 0 -CCTAGAAACAGTGTGGCAATGTGAA-3 0 and 5
Plasmid Construction and mRNA Preparation for Microinjection A full-length cDNA clone, XL023o21, was isolated from XDB of the NIBB/NIG Xenopus EST database, then inserted in-frame into the EcoRI and XhoI sites of the pCS2+ plasmid by PCR. xANR5, including the 5 0 UTR, and xANR5 in which silent mutations were introduced (a rescue construct, xANR5) were also inserted into the pCS2+ or pCS2-Venus plasmid. GAL4-DBD-tagged c-jun (100 pg injected) was a kind gift from M. Tada. Plasmids to be used for microinjection were linearized with NotI, and capped mRNAs were synthesized as described [12] .
RNA Isolation and RT-PCR Analysis
Total RNA was isolated from 10 explants with Trizol reagent (Life Technologies), according to the manufacturer's instructions. Experiments were carried out as previously described [7] . The gel images were scanned and quantified with a FLA2000 Bioimager with built-in software (Fuji Film, Japan).
Cytological Observation by Confocal Microscopy
To observe the subcellular localization of the Venus, RFP, myc, and flag-tagged constructs, we used confocal laser scanning microscopy (Carl Zeiss MicroImaging) with built-in LSM 501 software.
ACs isolated at the blastula stage were mounted on a glassbottomed dish (3910-035; Iwaki). DMZ or VMZ explants were mounted on a glass-bottomed dish coated with fibronectin (w4-10 mg/ml, F1141; Sigma-Aldrich), followed by incubation until the proper stages. Immunostained explants were mounted on a glass slide (Matsunami, JAPAN) or a glass-bottomed dish by Gel/Mount (Biomeda, Foster City, CA). All images were prepared for publication with Adobe Photoshop.
Cell Spreading, Single-Cell Protrusion, and Cell Dissociation and Reaggregation Assay DMZs isolated at stage 10.5 were dissociated in calcium-magnesium-free medium (CMFM). For the cell-spreading and -protrusion assay, dissociated cells were plated on a fibronectin-coated glass-bottomed dish, then cultured for an hour before observation. The unattached cells were gently washed away. For the cell-spreading assay, the morphology of cells attached to the fibronectincoated dish was examined by phase-contrast microscopy. We counted the flattened cells that exhibited a multipolar cell shape as spreading cells. To observe the membrane-protrusive morphology, the behaviors of adherent cells were recorded as time-lapse movies. For the dissociation and reaggregation assay, isolated DMZs were gently rocked in CMFM for 1 hr, and then incubated for 3 hr after 4 mM calcium was added to the CMFM.
JNK Assay and Rho Activation Assay
To examine JNK activity, ten ACs from embryos that had received microinjections of GAL4-DBD-tagged c-jun (100 pg) with MO and/ or mRNA into two animal blastomeres at the 2-cell stage were used. A mouse anti-GAL4-DBD antibody (Santa Cruz) and rabbit anti-phospho c-jun antibody (Cell Signaling) were used to detect the total c-jun and phosphorylated c-jun, respectively. The Rho activation assay was carried out as described [21, 22] by a Rho Activation Assay Biochem Kit (Cytoskeleton, CO).
Protein-Protein Interaction, SDS-PAGE, and Western Blotting Epitope-fused proteins were harvested from 293T cells, then precipitated with a mouse anti-flag antibody (Sigma-Aldrich) or mouse anti-GST antibody (Santa Cruz). SDS-PAGE and western blotting were carried out as previously described [7, 12] . The antibodies used in the western blotting were as follows: rabbit anti-GFP antibody (Molecular Biological Laboratories), mouse anti-myc antibody, mouse anti-GST antibody (Santa Cruz), mouse anti-flag antibody (Sigma-Aldrich), rabbit anti-flag antibody (Sigma-Aldrich), mouse anti-Rho antibody (Clontech), and rabbit anti-RhoA (119) antibody (Santa Cruz), HRP-conjugated anti-rabbit anti-IgG, and HRP-conjugated anti-mouse anti-IgG (Amersham). The ECL Plus kit (Amersham) was used for detection.
Whole-Mount In Situ Hybridization and Immunohistochemistry
The embryos, explants, DIG (digoxigenin)-labeled RNA probes, Fluorescein-labeled RNA probes, and epitope-tagged synthetic mRNAs to be used for whole-mount in situ hybridization (WISH) and immunostaining were prepared and used as described [12, 25, 26] . For the immunostaining, a mouse anti-myc antibody (Santa Cruz) and a rabbit anti-flag antibody (Sigma-Aldrich) were used as the primary antibodies. Alexa 488-labeled mouse anti-IgG antibody (Molecular Probes) and Alexa 555-labeled rabbit anti-IgG antibody (Molecular Probes) were used to detect the primary antibodies. For the WISH, we used an alkaline phosphatase-conjugated antifluorescein antibody (Roche) for Fluorescein-labeled probes and an alkaline phosphotase-conjugated anti-DIG antibody (Roche) for DIG-labeled probes. Embryos were stained with BCIP (Roche) and BCIP+NBT (both from Roche) or BM Purple (Roche) in alkaline phosphatase buffer.
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